JPMorgan Resumes Allergen (AGN) at Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. PINS
4. COIN
5. RDDT
6. FSLR
7. SYK
8. SBUX
9. MA
10. FND

Go back to JPMorgan Resumes Allergen (AGN) at Overweight

Allergan Reiterates Strong Standalone Growth Profile and Strategy Following Termination of Pfizer Transaction

April 6, 2016 6:45 AM EDT

DUBLIN, April 6, 2016 /PRNewswire/ -- Allergan plc (NYSE: AGN) announced that its merger agreement with Pfizer (NYSE: PFE) has been terminated by mutual agreement, effective today. In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO

Allergan reiterated its compelling standalone growth profile and strategy following the... More